Partex

Between 2013 and 2015, 218 drugs failed in Stage 2 or Stage 3 trials1. While their creators deemed them unworthy of further pursuit, the data they generated remains valuable. Researchers elsewhere, if given access to that data, might find connections and identify new possibilities for success. Partex with a research-driven approach leverages one of the largest repositories of public and private datasets to realise the value of drug assets and identify the new possibilities. #Partex #ArtificialIntelligence #Technology #Healthcare

Join us, Gunjan Bhardwaj and Team Partex, at the esteemed 43rd J.P. Morgan Healthcare Conference! Discover groundbreaking advancements, from AI innovations to the future of drug development. See you in San Francisco! #JPMorganHealthcareConference #Healthcare #AI #Technology #ArtificialIntelligence #Partex

What’s the advice Gunjan Bhardwaj received that drove the innovation and success Partex? Watch as our CEO share the best business advice he ever received and how it shaped our journey of AI drug development. Gunjan Bhardwaj #Partex #AI #AITechnology

Inefficient drug asset development have far-reaching effects on human progress. Partex is dedicated to solving this challenge by enhancing pipeline efficiency and bringing drug assets to market faster. Together, let’s shape the future of healthcare through the power of AI. To know more, reach out at info@partex.io #AI #ArtificialIntelligence #Partex

At Partex, we revolutionize drug development with AI-powered asset management. We aim to deliver faster, effective disease solutions and transform global healthcare. To know more, reach out to us at info@partex.io Gunjan Bhardwaj #GunjanBhardwaj #AI #AITechnology #Partex

Partex is harnessing Artificial Intelligence to maximize pipeline potential and address the challenge of incurable diseases. Partex emerges as the world’s largest TechBioFin company that accelerates the speed-to-market in drug asset management. We are redefining how the breakthroughs in medicine are discovered, developed, and delivered. A new era in healthcare innovation begins here. To know more, reach out at info@partex.io #AITechnology #AI #Partex

Diseases progress relentlessly, and we need to keep up the pace by developing cures. Introducing Partex, the world's largest TechBioFin company, leveraging AI-powered drug asset management to transform healthcare. By accelerating drug discovery and development, we aim to redefine the future of drug asset management. To know more, reach out at info@partex.io #AITechnology #AI #Partex

Welcome to the Partex Family, Puja Bhardwaj! We are delighted to welcome Puja Kumari Bhardwaj as Senior Manager - Business Development at Partex Puja brings a wealth of experience in Sales and Business Development, working with clinical-stage Pharma and Biotech partners across the US, Europe, and India. Her expertise includes driving end-to-end sales and onboarding enterprise customers onto innovative eClinical platforms, Pharmacovigilance and Drug Safety monitoring SaaS applications, and cutting-edge cloud technologies. We’re excited about the incredible value Puja will bring to our team and look forward to achieving great milestones together. Welcome aboard, Puja! #WelcomeToTheTeam #NewHire #TeamPartex #BusinessDevelopment #PharmaIndustry #LifeSciences #SaaSInnovation #ProfessionalGrowth #Leadership #TogetherWeGrow

We are excited to share that Professor Dr. Dr. Prof. Juergen Scheele recently presented at the Arbeitsgemeinschaft Internistische Onkologie in der DKG-Herbstkongress, the prestigious Conference of the Internal Oncology Working Group in Berlin. Amrit - a Partex Company will build up the innovative AIO DataHub, a comprehensive platform for oncological Real-World Data. His presentation highlighted Partex’ capabilities for AI-driven solutions for healthcare and the life sciences - the reason why Partex can contribute to the pivotal AIO DataHub project. Using proprietary AI models, we aim to enhance patient care in oncology through improved data insights and drug optimization. Professor Scheele emphasized our exceptional capabilities in digital pharmaceutical optimization, in silico drug lifecycle modeling, and data integration and management, alongside our scientific excellence supported by a robust life sciences knowledge graph network. We extend our gratitude to the organizers of the AIO-Herbstkongress for this opportunity to engage in meaningful discussions on the future of oncology. We look forward to strengthening our collaborations! Arbeitsgemeinschaft Internistische Onkologie in der DKG #Partex #Oncology #AIinHealthcare #AIODataHub #Innovation #RWD

Looking for Germany’s fastest-growing startups? 🇩🇪 We’ve ranked the region’s fastest-growing companies in 2024 by revenue growth and followed their success stories to explore the trends and challenges shaping the ecosystem. Who’s leading the charge? Download the report to find out: https://lnkd.in/ecSeg3KE #siftedleaderboard #germany #startups